SpyGlass Pharma Inc. Common Stock
SGP | NASDAQ
$32.39
-$0.12 (-0.37%)
At close: Oct 30, 2026, 3:59 PM ET
$32.24
-$0.15 (-0.46%)
After-hours:
Oct 30, 2026, 7:30 PM ET
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 |
|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a |
Cost of Revenue | 875.73K | 534.73K | 216.73K | n/a |
Gross Profit | -875.73K | -534.73K | -216.73K | n/a |
Operating Income | -62.11M | -40.14M | -24.73M | -11.1M |
Interest Income | 6.05M | 3.95M | 2.36M | 1.29M |
Pretax Income | -56.05M | -36.19M | -22.37M | -9.82M |
Net Income | -56.05M | -36.19M | -22.37M | -9.82M |
Selling & General & Admin | 26.79M | 15.78M | 8.93M | 3.01M |
Research & Development | 34.66M | 24.04M | 15.8M | 8.09M |
Other Expenses | -216.73K | -216.73K | -216.73K | n/a |
Operating Expenses | 61.23M | 39.6M | 24.51M | 11.1M |
Interest Expense | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a |
Cost & Expenses | 62.11M | 40.14M | 24.73M | 11.1M |
Income Tax Expense | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 33.44M | 19.93M | 33.43M | 33.43M |
Shares Outstanding (Diluted) | 33.44M | 19.93M | 33.43M | 33.43M |
EPS (Basic) | -1.66 | -1.07 | -0.38 | n/a |
EPS (Diluted) | -1.66 | -1.07 | -0.38 | n/a |
EBITDA | -58.43M | -36.8M | -23.3M | -10.96M |
EBIT | -59.44M | -37.47M | -23.66M | -11.1M |
Depreciation & Amortization | 1.01M | 672K | 354K | 137.27K |
Add to Watchlist
Select watchlists to add or remove SGP